Eur Rev Med Pharmacol Sci 2015; 19 (21): 3993-3995

Effect of anti-oxidant agents in patients with hepatocellular diseases

R. Di Francia, L. Rinaldi, A. Troisi, F. Di Benedetto, M. Berretta

Laboratory of Molecular Haematology, National Cancer Institute, Fondazione “G. Pascale” IRCCS, Naples, Italy. mberretta@cro.it

Free PDF Download

To cite this article

R. Di Francia, L. Rinaldi, A. Troisi, F. Di Benedetto, M. Berretta
Effect of anti-oxidant agents in patients with hepatocellular diseases

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 21
Pages: 3993-3995

Keywords Related articles:

  1. Reply to the Letter “Effect of anti-oxidant agents in patients with hepatocellular diseases”
  2. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database
  3. New biological agents for the treatment of the “high risk” IBD patients
  4. Grouping of molecularly targeted anti-cancer agents based on cost-effectiveness analysis
  5. Anti-oxidant activity with inhibition of osteoclastogenesis by Atractylodes Rhizoma extract